All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

*Corynebacterium diphtheriae* is responsible for causing diphtheria which remains a major global cause of death (<http://www.who.int/immunization_monitoring/diseases/diphteria/>), and has conventionally been divided into four subgroups of biovars *i*.*e*., gravis, intermedius, mitis and belfanti based on biochemical characteristics according to Funke *et al*., 1997 \[[@pone.0186401.ref001]\] and Whitman *et al*., 2012 \[[@pone.0186401.ref002]\]. It was once a major cause of infant mortality, which spread as an epidemic and resulted in thousands of deaths \[[@pone.0186401.ref003]\]. The death rates dropped over time specifically in countries where living standards have improved, and the death rates rapidly declined after the introduction of immunization programs \[[@pone.0186401.ref003]\]. Despite these measures, it remains a significant pathogen around the globe, even today. A variety of mechanisms were responsible for causing such death rates; for example the 'strangling angel' effect on children that ascended from the wing shaped pseudo-membranes formed in the oropharynx. Disarticulation and impaction of these pseudo-membranes triggers acute airway obstruction and can result in sudden death \[[@pone.0186401.ref003], [@pone.0186401.ref004]\]. Since there has been a plethora of reported cases on both non-lethal and lethal diphtheria across various countries in the past few years, and that significant population displacements in the form of immigration are happening, more such cases are bound to follow. A passable handling requires quick inroads in discovering diphtheria antitoxin and antibiotic treatment \[[@pone.0186401.ref005]\].

Computational methods and other approaches, like reverse vaccinology, have been established for the rapid identification of novel targets in the post-genomic era \[[@pone.0186401.ref006], [@pone.0186401.ref007]\]. Approaches like subtractive and comparative microbial genomics as well as differential genome analysis \[[@pone.0186401.ref008]\] are being used for the identification of targets in a number of human pathogens like *M. tuberculosis \[[@pone.0186401.ref009]\]*, *Burkholderia pseudomalleii* \[[@pone.0186401.ref010]\], *Helicobacter pylori* \[[@pone.0186401.ref011]\] *Pseudomonas aeruginosa* \[[@pone.0186401.ref012]\], *Neisseria gonorrhea* \[[@pone.0186401.ref013]\] and *Salmonella typhi* \[[@pone.0186401.ref014]\].

The main principle is to find targeted genes/proteins that are essential for the pathogen and possess no homology counterpart in the host \[[@pone.0186401.ref015]\], such that drugs targeting these "pathogen-essential non-host homologs" can be applied with little (or no) off targets in the host. Some pathogen-essential proteins, though, may possess a certain degree of homology to host proteins. However, they might still be selected as potential molecular targets for structure-based selective inhibitor development. Significant differences in the active sites or in other druggable pockets might exist, such that the pathogenic protein could still be targeted \[[@pone.0186401.ref016], [@pone.0186401.ref017]\].

Here, we exploit an integrative *in silico* approach for the predictive proteome of *C*. *diphtheriae* species to associate the genomic information with the identification of putative therapeutic targets based on their three dimensional structure. It can be utilized for the identification of potent inhibitors, which might possibly lead to the discovery of compounds that inhibit pathogenic growth. The predicted proteomes from the 13 genomes of C. *diphtheriae* were modeled (pan-modelome) using the MHOLline workflow as proposed by Hassan *et al*., 2014 \[[@pone.0186401.ref018]\]. Furthermore, intra-species conserved proteins with adequate 3D models (core-modelome) were filtered on the basis of predicted essentiality for the bacteria, which leads to the identification of eight essential bacterial proteins. They were found non homologous to all host proteins and have been subjected to virtual screening using multiple compound libraries.

We provided a list of putative targets in *C*. *diphteriae*, and possible mechanisms to design peptide vaccines, and suggest novel lead, natural and drug-like compounds that could bind to the proposed target proteins.

Materials and methods {#sec002}
=====================

Genomes selection {#sec003}
-----------------

The thirteen *C*. *diphtheriae* strains, including three of the four biovars: gravis, mitis and belfanti **([Table 1](#pone.0186401.t001){ref-type="table"})** were included in this study. The gene and protein sequences of these thirteen *C*. *diphtheriae* strains were retrieved from NCBI (<ftp://ftp.ncbi.nih.gov/genomes/Bacteria>). The different steps involved in this computational approach for genome-scale modelome prediction and for the prioritization of putative drug and vaccine targets are given in (**Figs [1](#pone.0186401.g001){ref-type="fig"} & [2](#pone.0186401.g002){ref-type="fig"}**).

![Overview of different computational steps employed for the identification of putative essential targets (non-host homologous and host homologous) from the core-proteome of 13 *C*. *diphtheriae* strains.](pone.0186401.g001){#pone.0186401.g001}

![Intra-species subtractive modelomics workflow for conserved target identification in *C*. *diphtheriae* species.\
The table represents the total number of protein sequences as an input data fed to the MHOLline workflow (upper red arrow). The blue arrow represents the core genes of thirteen Cd strains. The rectangular boxes show how this workflow processes and filters a large quantity of genomic data for putative drug and vaccine target identification of a pathogen.](pone.0186401.g002){#pone.0186401.g002}

10.1371/journal.pone.0186401.t001

###### Strains of *C*. *diphtheriae* employed in the pan-modelome study with information on genomes statistics, disease prevalence and location of isolation.

![](pone.0186401.t001){#pone.0186401.t001g}

  Strain      GPID         NCBI Accession   Genome Size (Mb)   Proteins   GC%     Location   Biovar
  ----------- ------------ ---------------- ------------------ ---------- ------- ---------- ----------
  31A         PRJNA42399   NC_016799.1      2.53535            2258       53.60   Brazil     ---
  241         PRJNA42407   NC_016782.1      2.42655            2245       53.40   Brazil     ---
  BH8         PRJNA42423   NC_016800.1      2.48552            2223       53.60   Brazil     ---
  C7          PRJNA42401   NC_016801.1      2.49919            2230       53.50   USA        ---
  CDCE8392    PRJNA42405   NC_016785.1      2.43333            2135       53.60   USA        Mitis
  HC01        PRJNA42409   NC_016786.1      2.42715            2162       53.40   Brazil     Mitis
  HC02        PRJNA42411   NC_016802.1      2.46861            2179       53.70   Brazil     Mitis
  HC03        PRJNA42415   NC_016787.1      2.47836            2186       53.50   Brazil     Mitis
  HC04        PRJNA42417   NC_016788.1      2.48433            2190       53.50   Brazil     Gravis
  INCA402     PRJNA42419   NC_016783.1      2.44907            2163       53.70   Brazil     Belfanti
  PW8         PRJNA42403   NC_016789.1      2.53068            2200       53.70   USA        ---
  VA01        PRJNA42421   NC_016790.1      2.39544            2100       53.40   Brazil     Gravis
  NCTC13129   PRJNA87      NC_002935.2      2.48863            2185       53.50   UK         Gravis

Prediction of core-modelome and identification of core genome {#sec004}
-------------------------------------------------------------

To construct the core-modelome of *C*. *diphtheriae*, we followed a slightly modified protocol described by Hassan *et al*., 2014 \[[@pone.0186401.ref018]\]. High throughput structural modeling, MHOLline ([http://www.mholline.lncc.br](http://www.mholline.lncc.br/)), was used to predict the modelome (whole-proteome set of protein 3D models) for each strain. MHOLline uses comparative modeling approach for protein 3D structure prediction through MODELLER \[[@pone.0186401.ref019]\]. Our workflow also includes BLASTp (Basic Local Alignment Search Tool for Protein) \[[@pone.0186401.ref020]\], HMMTOP (Prediction of transmembrane helices and topology of proteins), \[[@pone.0186401.ref021]\] BATS (Blast Automatic Targeting for Structures), FILTERS, ECNGet (Get Enzyme Commission Number), MODELLER, and PROCHECK \[[@pone.0186401.ref022]\].

MHOLline work on the basis of available template. It is probable that MHOLline cannot detect all the common conserved proteins due to the unavailability of the template. To overcome this probability, we used EDGAR (an **E**fficient **D**atabase framework for comparative **G**enome **A**nalyses using BLAST score **R**atios for pan-genomics analysis) to collect common conserved genome as well of all Cd strains \[[@pone.0186401.ref023]\]. Later, the results from MHOLine and EDGAR were compared and crosschecked to obtain the final dataset of common conserved proteins.

Identification of intra-species conserved proteins {#sec005}
--------------------------------------------------

Primarily, for the identification of highly conserved proteins with available 3D models in all Cd strains (≥ 95% sequence identity), the standalone release of NCBI BLASTp+ (v2.2.26) was adapted from the NCBI ftp. Site (<ftp://ftp.ncbi.nlm.nih.gov/blast/executables/blast+/LATEST/>) and installed on a local machine. Furthermore, a search was performed using NCTC13129 as a random reference genome for all strains. Comparative genomics/proteomics approach was next adopted for selecting the highly conserved proteins using an all-against-all BLASTp analysis with a cut-off value of *E = 0*.*0001*, as in many other essentiality studies before \[[@pone.0186401.ref006], [@pone.0186401.ref013], [@pone.0186401.ref015], [@pone.0186401.ref018], [@pone.0186401.ref024]\].

Essential and non-host homologous (ENH) protein targets {#sec006}
-------------------------------------------------------

A subtractive genomics approach was next followed for the selection of conserved targets, which were essential to the bacteria \[[@pone.0186401.ref015]\]. Concisely, the set of proteins derived from the core-modelome of *C*. *diphtheriae* was subjected to the Database of Essential Genes (DEG) for homology analyses. The DEG encompasses experimentally validated data of currently available essential genomic elements like protein-coding genes and non-coding RNAs, from bacteria, archaea and eukaryotes. For a bacterium, essential genes form a minimal genome, i.e., a set of functional modules that has key roles in the emerging field of synthetic biology \[[@pone.0186401.ref025]\]. The cutoff values used for BLASTp were: *E-value = 0*.*0001*, *bit score ≥100* and *identity ≥ 25%* \[[@pone.0186401.ref015], [@pone.0186401.ref018]\].

The pool of essential genes was then subjected to NCBI-BLASTp (*E-value = 0*.*0001*, *bit score ≥100* and *identity ≥ 25%*) against the human genome for filtering pathogen-essential host-homologs \[[@pone.0186401.ref006]\]. The remaining set of pathogen-essential non-host homologs were additionally crosschecked with NCBI-BLASTp PDB database using the default values to find any remote structural similarity with the existing host homolog protein structures, keeping the cutoff level to ≤ 15% for query coverage. The biochemical pathways of these proteins have been checked using KEGG (Kyoto Encyclopedia of Genes and Genomes) \[[@pone.0186401.ref026]\], functionality using UniProt (Universal Protein Resource) \[[@pone.0186401.ref027]\], virulence using PAIDB (Pathogenicity island database) \[[@pone.0186401.ref028]\], and cellular localization using CELLO (subCELlular LOcalization predictor) \[[@pone.0186401.ref029]\]. The final list of targets was based on criteria described by Barh *et al*., 2011 & Hassan *et al*., 2014 \[[@pone.0186401.ref015], [@pone.0186401.ref018]\].

Essential and host homologous (EH) protein targets {#sec007}
--------------------------------------------------

We further extended our analyses to the set of protein targets that were essential to *C*. *diphtheriae* but homologous to host proteins. The essential protein targets deviating from the cutoff values for essential non-host homologous proteins were treated as host homologous proteins. This set of targets was also checked for pathway involvement, functional annotation virulence, and cellular localization as mentioned above.

Computational identification of druggable pockets {#sec008}
-------------------------------------------------

The information obtained from 3D structures and druggability analyses are important features for prioritizing and authenticating putative pathogen targets \[[@pone.0186401.ref030], [@pone.0186401.ref031]\]. As mentioned above, for druggability analyses, the final list of essential non-host and host homologous protein targets were subjected to DoGSiteScorer in PDB format \[[@pone.0186401.ref032]\]. The DoGSiteScorer is an automated pocket detection and analysis tool for calculating the druggability of protein cavities. For each detected cavity the tool returns the pocket residues and a druggability score ranging from 0 to 1. Values closer to 1 indicate highly druggable protein cavity, i.e. the predicted cavities are likely to bind ligands with high affinity \[[@pone.0186401.ref032]\]. The DoGSiteScorer also calculates volume, depth, surface area, lipophilic surface, and further parameters for each predicted cavity.

Ligand libraries preparation, virtual screening and docking analyses {#sec009}
--------------------------------------------------------------------

The ligand libraries were prepared from four different sources, compounds from ZINC database (ZINC drug-like molecules, ZINC Natural Product), natural compounds from literature survey \[[@pone.0186401.ref033]\] and the Di-terpenoid Iso-steviol derivatives (**[S1 Table](#pone.0186401.s001){ref-type="supplementary-material"}**). ZINC (drug-like molecules) contains 11,193 drug-like molecules, with Tanimoto cutoff level of 60% \[[@pone.0186401.ref034]\] and ZINC (Natural Product) contain 11,203 molecules. Whereas, the small library of natural compounds contained 28 molecules and the library of Di-terpenoid Iso-steviol derivatives contained 31 molecules respectively. The structures of these molecules were constructed using MOE-Builder tool. The 3D structures were modeled and partial charges were calculated using MOE (Molecular Operating Environment). The energies of the modeled molecules were minimized using the energy minimization algorithm of MOE tool (gradient: 0.05, Force Field: MMFF94X, Chiral Constraint) \[[@pone.0186401.ref035]\]. The modeled molecules were saved in the.mol2 file format and subjected to docking analysis.

The 3D structures of proteins were examined for structural errors such as missing atoms, wrong bonds and protonation states in the MVD (Molegro Virtual Docker) \[[@pone.0186401.ref036]\]. The consensus set of protein cavities and those predicted with DogSiteScorer (druggability ≥ 0.80) were compared with the MVD detected cavities, for all Cd targets. The maximum numbers of residues from DoGSiteScorer falling in the cavities detected by MVD were merged and final grid was generated based on the consensus between the highest scoring pocket from DoGSiteScorer and cavities detected by MVD for docking. The most druggable cavity was subjected to virtual screening using MVD. The program comprises of three search algorithms for molecular docking analyses namely MolDock Simplex Evolution (SE), MolDock Optimizer \[[@pone.0186401.ref036]\] and Iterated Simplex (IS). We employed the MolDock Optimizer search algorithm, which is based on a differential evolutionary algorithm, using the default parameters that are **a)** population size = 50, **b)** scaling factor = 0.5 and **c)** crossover rate = 0.9. The orientations of docked molecules from the library of natural compounds and from the derivatives of Di-terpenoid Iso-steviol were analyzed in Chimera \[[@pone.0186401.ref037]\]. The 200 top ranked compounds (ZINC drug-like molecules, ZINC Natural Product) for each target protein were evaluated for shape complementarity and hydrogen bond interactions. This led to the selection of a final set of compounds with polypharmacology and polypharmacy characteristics for target proteins in *C*. *diphtheriae*.

Results and discussion {#sec010}
======================

Modelome prediction and conserved targets identification in *C*. *diphtheriae* {#sec011}
------------------------------------------------------------------------------

Among 13 strains of *C*. *diphtheriae* species, our employed methodology produced high-confidence 3D structural models from orthologous proteins in *C*. *diphtheriae* species through the efficient MHOLline workflow (**[Fig 3](#pone.0186401.g003){ref-type="fig"}**). A comparative structural genomics approach was followed where all the G2 sequences classified as "Very High", "High", "Good" and "Medium to Good quality" by MHOLline, from the 12 Cd strains, were aligned to the Cd NCTC13129 strain as a reference genome. First, we identified a set of common conserved proteins with a pre-defined sequence similarity of 95--100%. This resulted in a set of 463 protein sequences, being conserved in all Cd strains (**[S3 Table](#pone.0186401.s003){ref-type="supplementary-material"}**).

![Efficiency of the MHOLline biological workflow for genome-scale modelome (3D models) prediction.\
Predicted proteomes from the genomes of 13 *C*. *diphtheriae* strains were fed to the MHOLline workflow in FASTA format. The grey bars represent the number of input data. The remaining bars (MHOLline output data) show the number of not aligned sequences (G0, green bars), sequences for which there is a template structure available at RCSB PDB (blue bars), and sequences with acceptable template structures that were modeled in the MHOLline workflow (G2, red bars).](pone.0186401.g003){#pone.0186401.g003}

Protein targets as putative drug and vaccine candidates {#sec012}
-------------------------------------------------------

The identification of essential proteins in *C*. *diphtheriae* was carried out where the core-modelome was compared to DEG (Database of Essential Genes). This filter drastically reduced the number of selected targets to 23 final targets. Further comparison of the corresponding protein sequences to the human host proteome resulted in a set of 8 targets as essential non-host homologous (ENH, **[Table 2](#pone.0186401.t002){ref-type="table"}**) and a set of 15 targets as essential host homologous proteins (EH, **[Table 3](#pone.0186401.t003){ref-type="table"}**).

10.1371/journal.pone.0186401.t002

###### Drug and/or vaccine target prioritization parameters and functional annotation of the eight essential non-host homologous putative targets.

![](pone.0186401.t002){#pone.0186401.t002g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene and protein codes   Official full name                                                                              Cavities with DS[^a^](#t002fn001){ref-type="table-fn"} [\>]{.ul} 0.80   Cavities with DS[^a^](#t002fn001){ref-type="table-fn"}^,^[^g^](#t002fn007){ref-type="table-fn"} [\>]{.ul} 0.60 and \< 0.80   Mol. Wt[^b^](#t002fn002){ref-type="table-fn"}\   Functions[^c^](#t002fn003){ref-type="table-fn"}                                                                          Cellular component[^d^](#t002fn004){ref-type="table-fn"}   Pathways[^e^](#t002fn005){ref-type="table-fn"}                                               Virulence[^f^](#t002fn006){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                (KDa)                                                                                                                                                                                                                                                                                                                             
  ------------------------ ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------- -------------------------------------------------------------------------------------------- -------------------------------------------------
  NP_939692.1, **nusB**    Transcription antitermination protein NusB/ N utilization substance protein B homolog           0                                                                       2                                                                                                                            20.382                                           **MF:** RNA binding.\                                                                                                    \                                                          unknown                                                                                      No
                                                                                                                                                                                                                                                                                                                                                                                 **BP:** DNA-templated transcription, termination, regulation of transcription, DNA-templated.                            Cytoplasm\                                                                                                                                              

  NP_939612.1, **hisE**    Phosphoribosyl-ATP pyrophosphatase                                                              0                                                                       1                                                                                                                            9.877                                            **MF:** RNA binding, phosphoribosyl-ATP diphosphatase activity\                                                          Cytoplasm\                                                 Biosynthesis of amino acids                                                                  Yes
                                                                                                                                                                                                                                                                                                                                                                                 **BP:** histidine biosynthetic process                                                                                                                                                                                                                                           

  NP_939445.1,\            Iron ABC transporter membrane protein/ Putative iron transport membrane protein, FecCD-family   2                                                                       3                                                                                                                            35.470                                           **MF:** Transporter activity\                                                                                            Membrane\                                                  The ATP-binding cassette (ABC) transporters form one of the largest known protein families   Yes
  **DIP1084**                                                                                                                                                                                                                                                                                                                                                                    **BP:** Transport                                                                                                                                                                                                                                                                

  NP_939345.1,\            Hypothetical protein DIP0983/ Uncharacterized protein                                           0                                                                       4                                                                                                                            28.193                                           **MF:** possible lysine decarboxylases (Pfam)/52% sequence identity with PDB Template 1WEK.\                             Cytoplasm\                                                 unknown                                                                                      Yes
  **DIP0983**                                                                                                                                                                                                                                                                                                                                                                    **BP:** A pyridoxal-phosphate protein. Also acts on 5-hydroxy-L-lysine (IUBMB Comments)                                                                                                                                                                                          

  NP_939302.1, **glpX**    Fructose 1,6-bisphosphatase II                                                                  3                                                                       2                                                                                                                            35.589                                           **MF:** fructose 1,6-bisphosphate 1-phosphatase activity, metal ion binding.\                                                                                                       Carbohydrate Metabolism                                                                      No
                                                                                                                                                                                                                                                                                                                                                                                 **BP:** gluconeogenesis, glycerol metabolic process                                                                                                                                                                                                                              

  NP_939123.1, **smpB**    SsrA-binding protein                                                                            1                                                                       2                                                                                                                            18.784                                           **MF:** RNA binding                                                                                                      Cytoplasm                                                  unknown                                                                                      Yes

  NP_938900.1, **rpsH**\   30S ribosomal protein S8                                                                        1                                                                       1                                                                                                                            14.292                                           **MF:** rRNA binding, structural constituent of ribosome\                                                                Extracellula/\                                             unknown                                                                                      No
                                                                                                                                                                                                                                                                                                                                                                                 **BP:** Translation                                                                                                      Cytoplasm                                                                                                                                               

  NP_938502.1, **bioB**\   Biotin synthase                                                                                 3                                                                       1                                                                                                                            38.224                                           **MF:** 2 iron, 2 sulfur cluster binding, 4 iron 4 sulfur cluster binding, biotin synthase activity, iron ion binding\   Cytoplasm                                                  Biotin metabolism                                                                            Yes
                                                                                                                                                                                                                                                                                                                                                                                 **BP:** biotin biosynthetic process                                                                                                                                                                                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Druggability predicted with DoGSiteScorer software. A druggability score above 0.60 is considered to be good, but a score above 0.80 is favored \[[@pone.0186401.ref032]\].

^b^Molecular weight was determined using ProtParam tool (<http://web.expasy.org/protparam/>).

^c^Molecular function (MF) and biological process (BP) for each target protein was determined using UniProt.

^d^Cellular localization of pathogen targets was performed using CELLO.

^e^KEGG was used to find the role of these targets in different cellular pathways.

^f^PAIDB was used to check if the putative targets are involved in the pathogen's virulence.

^g^DS = Drug Score

10.1371/journal.pone.0186401.t003

###### Drug and/or vaccine target prioritization parameters and functional annotation of the fifteen essential host homologous putative targets.

![](pone.0186401.t003){#pone.0186401.t003g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene and protein codes   Official full name                                     Cavities with DS[^a^](#t003fn001){ref-type="table-fn"} [\>]{.ul} 0.80   Cavities with DS[^a^](#t003fn001){ref-type="table-fn"}^,^[^g^](#t003fn007){ref-type="table-fn"} [\>]{.ul} 0.60 and \< 0.80   Mol. Wt[^b^](#t003fn002){ref-type="table-fn"}.\   Functions[^c^](#t003fn003){ref-type="table-fn"}                                                                                  Cellular[^d^](#t003fn004){ref-type="table-fn"} component   Pathways[^e^](#t003fn005){ref-type="table-fn"}                 Virulence[^f^](#t003fn006){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                       (KDa)                                                                                                                                                                                                                                                                                                        
  ------------------------ ------------------------------------------------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------------------- -------------------------------------------------
  NP_938651.1\             Recombination protein RecR                             0                                                                       2                                                                                                                            **23.901**                                        **MF:** DNA binding, metal ion binding\                                                                                          Cytoplasm                                                  Homologous recombination                                       **Yes**
  **RecR**                                                                                                                                                                                                                                                                                                                               **BP:** DNA recombination, DNA repair                                                                                                                                                                                                                      

  NP_938792.1\             Putative electron transport related protein            **0**                                                                   2                                                                                                                            **19.950**                                        **MF:** Antioxidant activity, oxidoreductase activity\                                                                           Cytoplasm/\                                                **---**                                                        **Yes**
  **DIP0411**                                                                                                                                                                                                                                                                                                                                                                                                                                                             Membrane                                                                                                                  

  NP_938922.1\             30S ribosomal protein S13                              **0**                                                                   1                                                                                                                            **13.777**                                        **MF:** rRNA binding, structural constituent of ribosome, RNA binding\                                                           Cytoplasm                                                  Ribosome                                                       **No**
  **rpsM**                                                                                                                                                                                                                                                                                                                               **BP:** Translation                                                                                                                                                                                                                                        

  NP_939046.1\             Putative uptake hydrogenase small subunit              **2**                                                                   0                                                                                                                            **43.949**                                        **MF:** 3 iron, 4 sulfur cluster binding, 4 iron, 4 sulfur cluster binding, ferredoxin hydrogenase activity, metal ion binding   Cytoplasm                                                  Microbial metabolism in diverse environments                   **Yes**
  **DIP0672**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  NP_939341.1\             Tetrahydropicolinate succinylase\                      **1**                                                                   1                                                                                                                            **33.780**                                        **MF:** 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity, magnesium ion binding\                      Cytoplasm                                                  Biosynthesis of amino acids                                    **Yes**
  **dapD**, DIP0979        **EC 2.3.1.117**                                                                                                                                                                                                                                                                                              **BP:** diaminopimelate biosynthetic process, lysine biosynthetic process via diaminopimelate                                                                                                                                                              

  NP_939343.1\             Putative succinyltransferase\                          **1**                                                                   1                                                                                                                            **33.039**                                        **MF:** 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity                                              Cytoplasm                                                  Biosynthesis of amino acids                                    **Yes**
  **DIP0981**              **EC 2.3.1.117**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  NP_939460.1\             Acetolactate synthase small subunit\                   **1**                                                                   3                                                                                                                            **19.063**                                        **MF:** acetolactate synthase activity, amino acid binding\                                                                      Cytoplasm/\                                                2-Oxocarboxylic acid metabolism                                **Yes**
  **ilvH**, DIP1099        **EC 2.2.1.6**                                                                                                                                                                                                                                                                                                **BP:** branched-chain amino acid biosynthetic process                                                                           Membrane                                                                                                                  

  NP_939590.1\             Precorrin-4 C11-methyltransferase\                     **1**                                                                   2                                                                                                                            **27.181**                                        **MF:** precorrin-2 dehydrogenase activity, precorrin-4 C11-methyltransferase activity\                                          Cytoplasm                                                  Porphyrin and chlorophyll metabolism                           **Yes**
  **cobM**                 **EC 2.1.1.133**                                                                                                                                                                                                                                                                                              **BP:** cobalamin biosynthetic process, porphyrin-containing compound biosynthetic process                                                                                                                                                                 

  NP_939786.1\             Putative transport membrane protein                    **4**                                                                   3                                                                                                                            **44.215**                                        **MF: T**ransporter activity\                                                                                                    Membrane                                                   The ATP-binding cassette (ABC) transporters                    **Yes**
  **DIP1438**                                                                                                                                                                                                                                                                                                                            **BP:** transmembrane transport                                                                                                                                                                                                                            

  NP_939832.1\             Putative uroporphyrinogen III methyltransferase        **3**                                                                   2                                                                                                                            **28.296**                                        **MF:** Methyltransferase activity\                                                                                              Cytoplasm                                                  Porphyrin and chlorophyll metabolism                           **Yes**
  **DIP1484**                                                                                                                                                                                                                                                                                                                            **BP:** oxidation-reduction process                                                                                                                                                                                                                        

  NP_939958.1\             Phospho-2-dehydro-3-deoxyheptonate aldolase\           **2**                                                                   3                                                                                                                            **50.805**                                        **MF:** 3-deoxy-7-phosphoheptulonate synthase activity\                                                                          Cytoplasm                                                  Biosynthesis of amino acids                                    **Yes**
  **aroH,** DIP1616        **EC 2.5.1.54**                                                                                                                                                                                                                                                                                               **BP:** aromatic amino acid family biosynthetic process                                                                                                                                                                                                    

  NP_940018.1\             Putative GTP cyclohydrolase 1 type 2 **EC 3.5.4.16**   **2**                                                                   1                                                                                                                            **40.657**                                        **MF:** GTP binding, GTP cyclohydrolase I activity, metal ion binding\                                                           Cytoplasm                                                  ---                                                            **Yes**
  **DIP1680**                                                                                                                                                                                                                                                                                                                            **BP:** 7,8-dihydroneopterin 3\'-triphosphate biosynthetic process                                                                                                                                                                                         

  NP_940228.1\             Serine acetyltransferase **EC 2.3.1.30**               **1**                                                                   0                                                                                                                            **20.208**                                        **MF:** serine O-acetyltransferase activity\                                                                                     Cytoplasm                                                  Carbon metabolism                                              **Yes**
  **cysE,** DIP1891                                                                                                                                                                                                                                                                                                                      **BP:** cysteine biosynthetic process from serine                                                                                                                                                                                                          

  NP_940284.1\             Putative pyruvate dehydrogenase                        **3**                                                                   1                                                                                                                            **62.497**                                        **MF:** Catalytic activity, magnesium ion binding, thiamine pyrophosphate binding                                                Cytoplasm                                                  (PYRUVATE METABOLISM) Nicotinate and nicotinamide metabolism   **Yes**
  **DIP1952**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  NP_940605.1\             Putative DNA protection during starvation protein      **0**                                                                   1                                                                                                                            **18.223**                                        **MF:** Ferric iron binding, oxidoreductase activity, oxidizing metal ions\                                                      Cytoplasm                                                  ---                                                            **Yes**
  **DIP2303**                                                                                                                                                                                                                                                                                                                            **BP:** cellular iron ion homeostasis, response to stress                                                                                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Druggability predicted with DoGSiteScorer software. A druggability score above 0.60 is usually considered, but a score above 0.80 is favored \[[@pone.0186401.ref032]\].

^b^ Molecular weight was determined using ProtParam tool (<http://web.expasy.org/protparam/>).

^c^ Molecular function (MF) and biological process (BP) for each target protein was determined using UniProt.

^d^Cellular localization of pathogen targets was performed using CELLO.

^e^KEGG was used to find the role of these targets in different cellular pathways.

^f^PAIDB was used to check if the putative targets are involved in the pathogen's virulence.

^g^DS = Drug Score.

Prioritization parameters for drug targets and vaccine candidates {#sec013}
-----------------------------------------------------------------

There are several factors that can aid in determining potential therapeutic targets \[[@pone.0186401.ref030]\]. For vaccine candidates, the information about subcellular localization is important: Proteins that contain transmembrane motifs are favored \[[@pone.0186401.ref024], [@pone.0186401.ref030], [@pone.0186401.ref038], [@pone.0186401.ref039]\]. The 23 essential proteins have a low molecular weight and all are localized in the cytoplasmic compartment of *C*. *diphtheriae* (**Tables [2](#pone.0186401.t002){ref-type="table"} & [3](#pone.0186401.t003){ref-type="table"}**). After the druggability evaluation using DoGSiteScorer \[[@pone.0186401.ref032]\] for both essential non-host and host homologous conserved targets from *C*. *diphtheriae*, we could predict at least one druggable cavity for each Cd target. The host homologous proteins as therapeutic targets could adversely affect the host. Therefore, the first step in numerous *in silico* drug target identification approaches are filtering proteins homologous to host proteome. Thus, we only consider the eight pathogen-essential non host homologs for the docking studies \[[@pone.0186401.ref013], [@pone.0186401.ref015], [@pone.0186401.ref040]\]. For the eight pathogen-essential non host homologs (**[S2 Table](#pone.0186401.s002){ref-type="supplementary-material"}**) glpX, nusB, rpsH, hisE, DIP1084, DIP0983, smpB, and bioB 3, 0, 1, 0, 2, 0, 1 and 3 cavities with score [\>]{.ul} 0.80 were predicted. The cavity of each protein exhibiting the highest druggability score was subjected to docking analyses. The numbers of predicted cavities with their respective druggability scores are given in **Tables [2](#pone.0186401.t002){ref-type="table"} & [3](#pone.0186401.t003){ref-type="table"}**.

The identified eight non-host homologous and essential Cd proteins could be novel therapeutic targets for *Corynebacterium diphtheriae*.

As per our knowledge, glpX, hisE and bioB proteins have been reported as potential drug target in *Mtb*. Protein nusB is a member of Nus-transcription Factor family that help bacteria in the process of elongation, transcription: translation coupling and termination. Some members of this family (nusG) has already been reported as drug target. Furthermore, rpsH and smpB are also reported as potential drug target by Folador et al., 2016 in their *in silico* study \[[@pone.0186401.ref041]\]. Protein DIP1084 is Putative iron transport membrane protein (FecCD-family) and DIP0983 is uncharacterized Hypothetical Protein that need to be characterized experimentally. Hence, these protein could be a good therapeutic target against Cd.

Virtual screening and molecular docking {#sec014}
---------------------------------------

For each target protein (glpX, nusB, rpsH, hisE, DIP1084, DIP0983, smpB, and bioB) four different libraries were separately screened. A total of 28 molecules from natural compounds library and 31 compounds from the derivatives of Di-terpenoid Iso-steviol library were docked. Furthermore, top 200 drug-like molecules from virtual screening analyses of two large libraries (ZINC drug-like molecules, ZINC Natural Product) were examined one-by-one for the selection of the final set of promising molecules that showed favorable interactions with the ENH targets. The biological importance and an analysis of the predicted protein-ligand interaction/s for each target are described here. The molecule names, ZINC codes and MolDock scores for the selected ligands, as well as the number of predicted hydrogen bonds with the protein cavity residues involved in these interactions, are shown below (**Tables [4](#pone.0186401.t004){ref-type="table"}--[11](#pone.0186401.t011){ref-type="table"}**) for each target protein. The predicted binding modes of selected ligands are also shown for each pathogen target in **Figs [5](#pone.0186401.g005){ref-type="fig"}--[12](#pone.0186401.g012){ref-type="fig"}.**

Validation of docking protocol {#sec015}
------------------------------

To validate the accuracy of MolDock program (MVD), the co-crystallized ligand of Biotin synthase, bioB (PDB ID; 1R30) was extracted and then re-docked into the binding pocket of receptor protein. The RMSD between docked and co-crystallized ligand was found to be 1.81 A˚, which shows that the adopted docking protocol is valid and can be used to correctly predict the binding pose of the ligands \[[@pone.0186401.ref035], [@pone.0186401.ref042]\]. The superposition of co-crystallized ligands and docked is shown in **[Fig 4](#pone.0186401.g004){ref-type="fig"}.**

![Superposition of co-crystallized and Docked ligand; Dark Khaki represents the co crystallized ligand and Dark Cyan the re-docked conformation of the ligand.](pone.0186401.g004){#pone.0186401.g004}

**NP_939302.1** (**glpX,** Fructose 1, 6-bisphosphatase II) is a key enzyme of gluconeogenesis and catalyzes the hydrolysis of fructose 1, 6-bisphosphate to form fructose 6-phosphate and orthophosphate. A reverse reaction catalyzed by phosphofructokinase in glycolysis, and the product, fructose 6-phosphate, is an important precursor in various biosynthetic pathways \[[@pone.0186401.ref043]\]. In all organisms, gluconeogenesis is an important metabolic pathway that allows the cells to synthesize glucose from non-carbohydrate precursors, such as organic acids, amino acids and glycerol. FBPases are members of the large superfamily of lithium sensitive phosphatases, which includes three families of inositol phosphatases and FBPases (the phosphoesterase clan CL0171, 3167 sequences, Pfam data base). The FBPases are already reported as targets for the development of drugs for the treatment of noninsulin dependent diabetes \[[@pone.0186401.ref044], [@pone.0186401.ref045]\]. Based on a comparison with a crystallographic structure of the glpX template (PDB ID: 1NI9, GlpX from *Escherichia coli*), none of the active site residues were identified. The docking analysis was performed utilizing the highest scoring pocket obtained from DoGSiteScorer. **[Table 4](#pone.0186401.t004){ref-type="table"}**shows a set of 10 promising ligands according to their minimum energy values and the maximum number of hydrogen bond interactions from the four aforementioned libraries. Compounds **ZINC67912153, ZINC13142972,** Jacarandic Acid and 16-hydrazonisosteviol are shown in **[Fig 5](#pone.0186401.g005){ref-type="fig"}**.

![**A-I:** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939302.1** (glpX, Fructose 1,6-bisphosphatase II) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structures of Jacarandic Acid with glpX protein. Figs **B-I, II**, **C-I, II** & **D-I, II** represent same information for compounds 16-hydrazonisosteviol, **ZINC13142972** and **ZINC67912153** respectively, for the same protein cavity.](pone.0186401.g005){#pone.0186401.g005}

10.1371/journal.pone.0186401.t004

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected best-ranked molecules against NP_939302.1 (glpX, Fructose 1,6-bisphosphatase II).

![](pone.0186401.t004){#pone.0186401.t004g}

  Compounds                                                                   MolDock Score           H-Bond/Residues                               
  --------------------------------------------------------------------------- ----------------------- --------------------------------------------- ---------------------------------------------------------------------
  **Plant derived natural compounds**                                         Rhein                   -64.1265                                      3/ Val95, Asp197
  Jacarandic Acid                                                             -62.0658                4/ Asp96, Thr98, Asp197, Pro221               
  **Derivative of diterpenoid isosteviol**                                    16-hydrazonisosteviol   -64.2107                                      5/ Asp93, Val95, Asp96, Val198
  16-oxime, 17-hydroxyisosteviol                                              -69.6824                4/ Asp93, Asp96, Thr98                        
  Benzyl ester isosteviol lactone                                             -69.8464                3/ Asp93, Asp197, Glu222                      
  **ZINC Compounds**                                                          ZINC00042420            -106.97                                       3/ Arg175, Arg197, Val198
  ZINC13142972                                                                -109.648                3/ Asp93, Asp197, Glu222                      
  **ZINC** [**[\*](#t004fn001){ref-type="table-fn"}**]{.ul}**NP Compounds**   ZINC67912153            -135.111                                      13/Gly64, Glu65, Asp93, Val95, Gly97, Thr98, Phe127, Arg175, Glu222
  ZINC67902753                                                                -121.762                8/Glu65, Val95, Thr98, Glu222                 
  ZINC38143633                                                                -123.150                11/Lys37, Asp93, Val95, Asp96, Gly97, Thr98   

\*NP = Natural Product (<http://zinc.docking.org/catalogs/acdiscnp>)

**NP_939692.1** (**nusB,** Transcription antitermination protein NusB) is a prokaryotic transcription factor involved in antitermination processes, during which it interacts with the mRNA nut site at boxA portion. The crystal structure of *M*. *tuberculosis* and *E*. *coli* NusB proteins suggest that the basic N-terminal region of the molecule associates with the rRNA BoxA. Hypothetically, this is indicative of the so-called arginine rich RNA binding motif (ARM) in the bacteriophage N protein, HIV tat and HIV rev. This suggestion is supported by the presence of a phosphate-binding site at the N-terminal end of α-A in each NusB protomer that includes a pair of conserved arginines, Arg10 and Arg14 \[[@pone.0186401.ref046]\]. The bismuth-dithiol solutions have been shown to selectively inhibit *Escherichia coli* rho transcription termination factor \[[@pone.0186401.ref047]\]. A comparison between the crystallographic structures of the NusB template (PDB ID: 1EYV, NusB from *M*. *tuberculosis*) and our modeled structure reveals that the conserved arginines were located at position 12 and 16 (Arg12 and Arg16) and are likely to contribute in the interactions. Although none of these residues are predicted to form hydrogen bonds with selected docked ligands, these molecules were predicted to interact with other residues in the pocket. **[Table 5](#pone.0186401.t005){ref-type="table"}**shows the 8 selected ligands from all the four libraries according to their minimum energy values and the number of hydrogen bond interactions. The compounds **ZINC15043210, ZINC00053531** Jacarandic Acid and 16-hydrazonisosteviol are shown in **([Fig 6](#pone.0186401.g006){ref-type="fig"})**. A decent binding mode and good shape complementarity was observed in these complexes.

![**A-I:** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939692.1** (**nusB,** Transcription antitermination protein NusB) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structures of Jacarandic Acid with nusB protein. Figs **B-I, II**, **C-I, II** and **D-I, II** represent same information for compounds 16-hydrazonisosteviol, **ZINC00053531** and **ZINC15043210** respectively, for the same protein cavity.](pone.0186401.g006){#pone.0186401.g006}

10.1371/journal.pone.0186401.t005

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939692.1 (nusB, Transcription antitermination protein NusB).

![](pone.0186401.t005){#pone.0186401.t005g}

  Compounds                                  MolDock Score           H-Bond/Residues                                
  ------------------------------------------ ----------------------- ---------------------------------------------- --------------------------------------
  **Plant derived natural compounds**        Rhein                   -78.0652                                       1/ Asp36
  Jacarandic Acid                            -68.1913                3/ Asp36, Glu91, Arg98                         
  **Derivative of diterpenoid isosteviol**   16-hydrazonisosteviol   -92.7911                                       2/ Glu31, Leu73
  **ZINC Compounds**                         ZINC00053531            -99.4716                                       3/ Asp34, Asp36, Ala69
  ZINC19899354                               -114.966                3/ Asp36, Ala69, Asp77                         
  **ZINC NP Compounds**                      ZINC67911826            -131.288                                       7/Ala30, Glu31, Asp34, Ile35, Arg102
  ZINC15043210                               -124.580                7/ Glu31, Ile35, Leu73 Glu91, Arg102           
  ZINC31168395                               -131.442                6/ Glu31, Asp34, Ala69, Leu73, Asp77, Arg102   

**NP_938900.1** (**rpsH,** 30S ribosomal protein S8) is an important RNA-binding protein that inhabits a central position within the small ribosomal subunit. It widely interacts with 16S rRNA and is vital for the correct folding of the central domain of the rRNA. The protein rpsH S8 also controls the synthesis of numerous ribosomal proteins by binding to mRNA. It binds exactly to very similar sites in the two RNA molecules. It is a ribosomal protein that has medium-size, and its role as a significant primary RNA-binding protein in the 30S subunit is discovered recently. The S8 mutations within the protein have been shown to result in defective ribosome assembly. In *Escherichia coli*, the S8-binding site within 16S rRNA has been investigated independently by a number of techniques including nuclease protection, RNA--protein crosslinking, RNA modification, hydroxyl-radical footprinting and chemical probing. The rpsH S8 protein is also one of the principal regulatory elements that control ribosomal protein synthesis by the translational feedback inhibition mechanism discovered by Nomura and colleagues \[[@pone.0186401.ref048]\]. It regulates the expression of the spc operon that encodes, in order, the ten ribosomal proteins L14, L24, L5, S14, S8, L6, L18, S5, L30 and L15 \[[@pone.0186401.ref049]\]. The active site residues of rpsH, based on a comparison with its template structure were Arg86, Tyr88, Ser107, Ser109, Gly124, Gly125 and Glu126. However, none of the molecules interacts with these residues (**[Table 6](#pone.0186401.t006){ref-type="table"}**); nonetheless they are predicted to interact with other residues of the binding cavity predicted by DoGSiteScorer. The predicted binding mode of best scoring compounds each library **ZINC35457686**, **ZINC15221730**, Jacarandic Acid and 17-hydroxyisosteviol are shown in **[Fig 7](#pone.0186401.g007){ref-type="fig"}.**

![**A-I** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_938900.1** (**rpsH,** 30S ribosomal protein S8) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structures of Jacarandic Acid with rpsH protein. Figs **B-I, II**, **C-I, II** and **D-I, II** represent same information for compounds 17-hydroxyisosteviol **ZINC15221730** and **ZINC35457686** respectively, for the same cavity.](pone.0186401.g007){#pone.0186401.g007}

10.1371/journal.pone.0186401.t006

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938900.1 (rpsH, 30S ribosomal protein S8).

![](pone.0186401.t006){#pone.0186401.t006g}

  Compounds                                  MolDock Score           H-Bond/Residues                               
  ------------------------------------------ ----------------------- --------------------------------------------- ---------------------------------------------------
  **Plant derived natural compounds**        Rhein                   -48.8803                                      3/ Asp5, Arg15
  Jacarandic Acid                            -49.3506                4/ Ser12, Val77                               
  **Derivative of diterpenoid isosteviol**   16-hydrazonisosteviol   -68.2446                                      3/ Asp5, Arg13, Arg79
  17-hydroxyisosteviol                       -64.5855                5/ Asp5, Arg79                                
  16--17 dihydroxyisosteviol                 -56.3868                4/ Asp5, Arg79                                
  16-oxime, 17-hydroxyisosteviol             -65.1995                4/ Ser26, Ser29, Ser30                        
  **ZINC Compounds**                         ZINC15221730            -103.636                                      5/ Ala8, Arg15, Arg79
  ZINC71913776                               -87.1474                5/ Arg15, Arg79                               
  ZINC72333100                               -104.807                3/ Arg15, Arg79, Val80                        
  **ZINC NP Compounds**                      ZINC35457686            -107.091                                      10/Ala8, Ser12, Arg15, Val77, Arg78, Arg79, Lys82
  ZINC67903079                               -131.210                10/ Asp5, Ser12, Arg15, Arg78, Arg79, Lys82   
  ZINC31163223                               -100.684                7/ Ala8, Asp9, Arg78, Arg79, Lys82            

**NP_938502.1** (**bioB,** Biotin synthase) catalyzes the final step in the biotin biosynthetic pathway by converting dethiobiotin (DTB) to biotin. This reaction uses organic radical chemistry for inserting sulfur atom between non activated carbons C6 and C9 of DTB. BioB is a member of the "radical SAM" or "AdoMet radical" superfamily, which is categorized by the presence of a conserved CxxxCxxC sequence motif (C, Cys; x, any amino acid) that synchronizes an essential Fe~4~S~4~ cluster, as well as by the use of S-adenosyl-Lmethionine (SAM or AdoMet) for radical generation. AdoMet radical enzymes act on a wide variety of biomolecules. For example, BioB and lipoyl-acyl carrier protein synthase (LipA) are involved in vitamin biosynthesis; lysine 2,3-aminomutase (LAM) facilitates the fermentation of lysine; class III ribonucleotide reductase (RNR) and pyruvate formate lyase (PFL) catalyze the formation of glycyl radicals in their respective target proteins; and spore photoproduct lyase repairs ultraviolet light-induced DNA damage \[[@pone.0186401.ref050]\]. The protein bioB was reported as putative drug target in *C*. *diphtheriae* by Barh *et al*., 2011 in their in silico study \[[@pone.0186401.ref015]\]. A comparison between our modeled protein and template structures suggest Cys86, Cys90, Cys93 and Arg291 as the active residues. Although, only Cys86, Cys90 and Cys93 were found to interact with the compounds from our prepared libraries, the molecules were predicted to interact with other residues in the pocket. The binding mode of compounds with active site residues and low scores suggest a set of 10 molecules (**[Table 7](#pone.0186401.t007){ref-type="table"}**) as promising leads from our four libraries. The predicted binding modes of Jacarandic Acid, 16-oxime, 17-hydroxyisosteviol, **ZINC16952914** and **ZINC77269615** are shown in **[Fig 8](#pone.0186401.g008){ref-type="fig"}**.

![**A-I** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_938502.1** (**bioB,** Biotin synthase) with Rhein (CID 10168). **A-II:** 3D surface representation of the docking analyses for the structure of Rhein with bioB protein. Figs **B-I, II**, **C-I, II** & **D-I, II** represent same information for compounds 16-oxime, 17-hydroxyisosteviol, **ZINC16952914** and **ZINC77269615** respectively, for the same protein cavity.](pone.0186401.g008){#pone.0186401.g008}

10.1371/journal.pone.0186401.t007

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_938502.1 (bioB, Biotin synthase).

![](pone.0186401.t007){#pone.0186401.t007g}

  Compounds                                  MolDock Score           H-Bond/Residues                                                                           
  ------------------------------------------ ----------------------- ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------
  **Plant derived natural compounds**        Rhein                   -72.2918                                                                                  3/ Tyr183, Asn184, His185
  Jacarandic Acid                            -98.0169                2/ Ala132, Glu188                                                                         
  **Derivative of diterpenoid isosteviol**   16-hydrazonisosteviol   -107.55                                                                                   4/ Gly165, Tyr183, Asn184, Glu188
  17-hydroxyisosteviol                       -92.2141                4/ Cys93, Ala132, Val134, Tyr183                                                          
  16-oxime, 17-hydroxyisosteviol             -98.9592                5/ Glu95, Val134, Glu188, Arg206, Thr323                                                  
  Benzyl ester isosteviol lactone            -89.8881                5/ Ala132, Val134, Gly165, Asn184                                                         
  **ZINC Compounds**                         ZINC16952914            -119.354                                                                                  5/ Val134, Ile164, Gly165, Asn184, Asn186
  **ZINC NP Compounds**                      ZINC77269615            -164.853                                                                                  17/Cys86, Phe92, Cys93, Ser94, Gln95, Ala132, Val134, Ser163, Asn184, Asn186, Arg206
  ZINC04098512                               -162.050                14/ Cys86, Cys90, Cys93, Ala132, Val134, Asn184, Asn186, His201, Arg206, Asp256, Thr323   
  ZINC15112225                               -142.080                10/ Phe92, Cys93, Ser94, Gln95, Asn186, Arg206, Asn253                                    

**NP_939612.1** (**hisE,** Phosphoribosyl-ATP pyrophosphatase) is the second enzyme in the histidine-biosynthetic pathway, hydrolyzing irreversibly phosphoribosyl-ATP to phosphoribosyl-AMP and pyrophosphate. It is encoded by the *hisE* gene, which is present as a separate gene in many bacteria and archaea but is fused to *hisI* in other bacteria, fungi and plants. As it is essential for growth as seen in *in vitro* experiments, HisE is a potential drug target for tuberculosis \[[@pone.0186401.ref051]\]. A comparison of template and target protein structures here showed that there was no reported information about ligand-residue/s association in the active site cavity. Hence, the cavity chosen for virtual screening was simply the one that presented the highest DogSiteScorer druggability score (\>80). A list of best dock molecules is shown below (**[Table 8](#pone.0186401.t008){ref-type="table"}**). The binding patterns of Jacarandic Acid, 16--17 dihydroxyisosteviol, **ZINC05809437** and **ZINC67913372** are shown in **[Fig 9](#pone.0186401.g009){ref-type="fig"}.**

![**A-1** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939612.1** (**hisE,** Phosphoribosyl-ATP pyrophosphatase) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structure of Jacarandic Acid with hisE protein. Figs **B-I, II**, **C-I, II** & **D-I, II** represent same information for compounds 16--17 dihydroxyisosteviol, **ZINC05809437** and **ZINC67913372** respectively, for the same protein cavity.](pone.0186401.g009){#pone.0186401.g009}

10.1371/journal.pone.0186401.t008

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939612.1 (hisE, Phosphoribosyl-ATP pyrophosphatase).

![](pone.0186401.t008){#pone.0186401.t008g}

  Compounds                                  MolDock Score                H-Bond/Residues                 
  ------------------------------------------ ---------------------------- ------------------------------- ------------------------
  **Plant derived natural compounds**        Rhein                        -54.9556                        1/ Tyr84
  Jacarandic Acid                            -61.0241                     3/ Leu87                        
  **Derivative of diterpenoid isosteviol**   16--17 dihydroxyisosteviol   -70.8496                        3/ Leu65, Tyr84
  **ZINC Compounds**                         ZINC05809437                 -89.6781                        1/ Asp5
  **ZINC NP Compounds**                      ZINC38143703                 -99.499                         4/ Thr79, Ile83, Leu87
  ZINC67913372                               -97.997                      5/ Gly36, Ile62, Ile83, Tyr84   

**NP_939123.1** (**smpB,** SsrA-binding protein) is a small protein B (SmpB), which is very useful for biological functions of tmRNA. In bacteria, a hybrid RNA molecule that combines the functions of both messenger and transfer RNAs rescues stalled ribosomes, and targets aberrant, partially synthesized proteins for proteolytic degradation. The flexible RNA molecule adopts an open L-shaped conformation and SmpB binds to its elbow region, stabilizing the single-stranded D-loop in an extended conformation. The most prominent feature of the structure of tmRNA~**Δ**~ is a 90^o^ rotation of the TѰC-arm around the helical axis. Because of this important conformation, the SmpB--tmRNA D-complex positioned into the A-site of the ribosome orients SmpB towards the small ribosomal subunit, and directs tmRNA towards the elongation-factor binding region of the ribosome. The tmRNA--SmpB rescue system is ubiquitous in bacteria, and is also found in some chloroplasts and mitochondria \[[@pone.0186401.ref052]\]. In this case the template structure (PDB ID: 1P6V) did not contain any ligand, and no reported information was found about the ligand-residue interaction in their cavities. Therefore, amongst the cavities identified by MVD, the best cavity for docking analysis was chosen in consensus with highest druggability score from the DogSiteScorer. **ZINC31168211** was found to form the network of 12 hydrogen bonds with Asn9, Ser16, Val49, Ser50, Thr52, Asp53, Ser54, Thr109. **[Table 9](#pone.0186401.t009){ref-type="table"}**lists top compounds from respective libraries selected for this target while the binding modes of Rhein, 16-hydroxyisosteviol, **ZINC01414475 and ZINC31168211** are also shown (**[Fig 10](#pone.0186401.g010){ref-type="fig"}).**

![**A-I** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939123.1** (**smpB,** SsrA-binding protein) with Rhein (CID 10168). **A-II:** 3D surface representation of the docking analyses for the structure of Rhein with smpB protein. Figs **B-I, II**, **C-I, II** & **D-I, II** represent same information for compounds 16-hydroxyisosteviol **ZINC01414475** & **ZINC31168211** respectively, for the same protein cavity.](pone.0186401.g010){#pone.0186401.g010}

10.1371/journal.pone.0186401.t009

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939123.1 (smpB, SsrA-binding protein).

![](pone.0186401.t009){#pone.0186401.t009g}

  Compounds                                  MolDock Score          H-Bond/Residues                                            
  ------------------------------------------ ---------------------- ---------------------------------------------------------- ------------------------------------------------------------
  **Plant derived natural compounds**        Rhein                  -67.698                                                    3/ Ser16, Ser114, Leu115
  Jacarandic Acid                            -52.3689               1/ Asn69                                                   
  **Derivative of diterpenoid isosteviol**   16-hydroxyisosteviol   -53.2141                                                   4/ Ser50, Thr52, Asn69
  16-hydrazonisosteviol                      -64.6203               3/ Thr52, Asn67                                            
  16--17 dihydroxyisosteviol                 -59.7364               3/ Ser16, Lys19, Val49                                     
  **ZINC Compounds**                         ZINC01414475           -86.7944                                                   3/ Thr52, Asn67, Asn69
  ZINC17128469                               -74.5349               3/ Ser16, Leu51, Thr52                                     
  **ZINC NP Compounds**                      ZINC31168211           -158.056                                                   12/ Asn9, Ser16, Val49, Ser50, Thr52, Asp53, Ser54, Thr109
  ZINC33832449                               -134.974               10/ Asn9, Ser16, Asn17, Val49, Ser50, Thr52, Asp53         
  ZINC04096316                               -137.613               9/ Asn9, Ser10, Ser16, Asn17, Lys19, Val49, Ser50, Thr52   

**NP_939445.1** (**DIP1084,** Putative iron transport membrane protein, FecCD-family) The Pfam search for the protein showed that it has two main components, FecCD and ABC_trans. The FecCD is a subfamily of bacterial binding-protein-dependent transport systems family constituting transport system permease proteins involved in the transport of numerous compounds through the membrane. These transporters tend to catalyze the thermodynamically unfavorable translocation of substrates against a transmembrane concentration gradient through the coupling to a second, energetically favorable process. ABC systems can be categorized in three functional groups, as follows. Importers mediate the uptake of nutrients in prokaryotes. The nature of the substrates that are transported is very wide, including mono- and oligosaccharides, organic and inorganic ions, amino acids, peptides, iron-siderophores, metals, polyamine cations, opines, and vitamins \[[@pone.0186401.ref053]\]. Exporters are involved in the secretion of various molecules, such as peptides, lipids, hydrophobic drugs, polysaccharides, and proteins, including toxins such as hemolysin. The third category of systems is apparently not involved in transport, with some members being involved in translation of mRNA and in DNA repair. **[Table 10](#pone.0186401.t010){ref-type="table"}**shows a set of 11 high scoring compounds against the proposed target. Compound **ZINC70454922** from ZINC NP library was predicted to form ten hydrogen bonds with relatively low docking score (**[Fig 11](#pone.0186401.g011){ref-type="fig"}**).

![**A-I** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939445.1** (**DIP1084,** Putative iron transport membrane protein, FecCD-family) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structure of Jacarandic Acid with **DIP1084,** Putative iron transport membrane protein. Figs **B-I, II, C-I, II** & **D-1, II D** represent same information for compounds 16-hydrazonisosteviol **ZINC13142972** and **ZINC70454922** respectively, for the same protein cavity.](pone.0186401.g011){#pone.0186401.g011}

10.1371/journal.pone.0186401.t010

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939445.1 (DIP1084, Putative iron transport membrane protein, FecCD-family).

![](pone.0186401.t010){#pone.0186401.t010g}

  Compounds                                  MolDock Score           H-Bond/Residues                                             
  ------------------------------------------ ----------------------- ----------------------------------------------------------- -----------------------------------------------------------
  **Plant derived natural compounds**        Rhein                   -66.4406                                                    1/ Ser164
  Jacarandic Acid                            -77.5981                1/ Gly265                                                   
  **Derivative of diterpenoid isosteviol**   16-hydrazonisosteviol   -96.3945                                                    4/ Tyr97, Ser164, Ile266
  17-hydroxyisosteviol                       -90.1488                4/ Tyr97, Ser164, Ile266                                    
  Benzyl ester isosteviol lactone            -71.4733                4/ Tyr97, Ser164                                            
  **ZINC Compounds**                         ZINC01645563            -95.7116                                                    5/ Tyr97, Ser102, Ser164, Ile266
  ZINC13142972                               -111.185                5/ Ser103, Ser106, Thr110, Ser164, Ser168                   
  ZINC62023045                               -103.542                4/ Tyr97, Ser102, Ser106, Ser164                            
  **ZINC NP Compounds**                      ZINC70454922            -155.667                                                    10/ Tyr97, Ser102, Ser106, Ser168, Ser172, Met191, Gly319
  ZINC31167925                               -135.535                10/ Tyr97, Ser164, Ser168, Met191, Gly265, Ile266, Thr322   
  ZINC04963990                               -127.671                8/ Asp95, Tyr97, Ser106, Met191, Ile266, Phe268             

**NP_939345.1** (**DIP0983,** Hypothetical protein DIP0983) is a conserved hypothetical protein. It is annotated as a possible lysine decarboxylase (LDC) in the Pfam database (PF03641) \[[@pone.0186401.ref054]\] due to the presence of the highly conserved PGGxGTxxE motif. Some enzymes *i*:*e* "Lonely Guy" LOG are often mis-annotated as lysine decarboxylases enzymes; it is apparently responsible for catalyzing L-lysine decarboxylation to produce the polyamine metabolite cadaverine \[[@pone.0186401.ref055]\]. Conversely, this annotation is not supported by any biochemical or functional data in any of the PGGxGTxxE motif containing LDC identified so far. This motif is highly conserved among a vast number of proteins with unknown function, predicted from bacterial, yeast, and plant; in *Arabidopsis thaliana*, all the genome-annotated LOG proteins are identified as LDC like proteins by protein family. Based on sequence BLAST against the PDB, LOG from *Claviceps purpurea* shares more than 30% identical residues with crystal structures of LDC-like proteins of unknown function, whose structures are already determined. Recently, lysine decarboxylase has been reported as a therapeutic target by Lohinai *et al*., 2015 for Periodontal Inflammation \[[@pone.0186401.ref056]\]. Here we listed 12 compounds showing good potency against our target tabulated in **[Table 11](#pone.0186401.t011){ref-type="table"}**. Four of the compounds with promising docking results are shown in **[Fig 12](#pone.0186401.g012){ref-type="fig"}.**

![**A-1:** 3D cartoon representation of the docking analyses for the most druggable protein cavity of **NP_939345.1** (**DIP0983,** Hypothetical protein DIP0983) with Jacarandic Acid (CID 73645). **A-II:** 3D surface representation of the docking analyses for the structure of Jacarandic Acid with Hypothetical protein DIP0983. Figs **B-I, II, C-I, II** & **D-I, II** represent same information for compounds 17-hydroxyisosteviol, **ZINC00211173** and **ZINC67911471** respectively, for the same protein cavity.](pone.0186401.g012){#pone.0186401.g012}

10.1371/journal.pone.0186401.t011

###### Compounds/Libraries name, MolDock scores and predicted hydrogen bonds for the selected molecules against NP_939345.1 (DIP0983, hypothetical protein DIP0983).

![](pone.0186401.t011){#pone.0186401.t011g}

  Compounds                                  MolDock Score          H-Bond/Residues                                          
  ------------------------------------------ ---------------------- -------------------------------------------------------- ---------------------------------------------------------------------
  **Plant derived natural compounds**        Rhein                  -55.7819                                                 3/ Cys13, Leu17, Asp177
  Jacarandic Acid                            -80.8294               3/ Cys13, Gly14                                          
  **Derivative of diterpenoid isosteviol**   17-hydroxyisosteviol   -95.9025                                                 2/ His11, Cys13
  16--17 dihydroxyisosteviol                 -83.7226               2/ His11, Cys13                                          
  **ZINC Compounds**                         ZINC00114311           -125.423                                                 6/ Arg10, Arg155, Gly172
  ZINC00211173                               -98.6064               7/ Arg10, Gly106, Arg155, Gly174, Asp177                 
  ZINC01427915                               -112.22                6/ Arg10, Ala77, Arg78, Gly172, Gly174                   
  ZINC04836994                               -136.847               5/ Arg10, Gly106, Ile131, Glu132                         
  ZINC32004947                               -146.72                5/ Arg10, Gly106, Ile131, Glu132                         
  **ZINC NP Compounds**                      ZINC67911471           -176.091                                                 13/ Asn8, Cys13, Ser76, Ala77, Arg78 Arg150, Arg155, Gly174, Thr175
  ZINC31163223                               -162.908               12/ Asn8, Arg10, His11, Arg150, Arg155, Gly172, Thr175   
  ZINC04096393                               -148.423               10/ Glu9, Arg10, Ala77, Arg78, Arg155, Lys156, Thr175    

Among the drug-like molecule **ZINC13142972 (**1-\[(2S, 3S, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl) oxolan-2-yl\]imidazo\[1,2-b\]pyrazole-7-carbonitrile) was predicted to show good results against two of our targets **NP_939302.1** (**glpX,** Fructose 1,6-bisphosphatase II) and **NP_939445.1** (**DIP1084,** Putative iron transport membrane protein, FecCD-family). It has been reported that at present 50% of drug molecules are either from natural source or their derivatives \[[@pone.0186401.ref057]\]. Interestingly, the compounds from second library of ZINC (Natural Product) showed better energy scores among all the libraries. Furthermore, from the library of natural compounds (28 molecules), Jacarandic Acid and Rhein were identified as the top ranked molecules and *in silico* analysis of the library (derivatives of diterpenoid isosteviol) suggest that compounds 16-hydroxyisosteviol, 16-hydrazonisosteviol, 17-hydroxyisosteviol, 16--17 dihydroxyisosteviol and 16-oxime, 17-hydroxyisosteviol were top ranked molecules, however, with much higher energy scores (less negative) than the top compounds from the ZINC libraries (ZINC drug-like molecules, ZINC Natural Product).

Conclusion {#sec016}
==========

We utilized a bioinformatics pipeline for determining the conserved proteome of 13 strains of *C*. *diphtheriae*, and subsequently exploit 3D structural information, resulting in a small set of prioritized putative drug/vaccine targets, of which eight proteins are pathogen-essential, non-host homologous and 15 are pathogen-essential, host-homologs. After a detailed structural comparison between host and pathogen proteins, we suggest that eight of the non -host homologs could be considered for antimicrobial chemotherapy in future studies on anti-diphtheriae drugs and vaccines. Moreover, the strategy described herein is of general nature and can also be employed to other pathogenic microorganisms.
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###### Structural information of the Di-terpenoid Iso-steviol derivatives.
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###### Information of templates used for 8 essential non host homologous targets.

(DOCX)

###### 

Click here for additional data file.

###### Common conserved proteins with their templates.
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DNA

:   Deoxyribonucleic acid
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